Joining us for this episode of Managed Care Cast is Robert H. Hopkins Jr, MD, medical director at the National Foundation for Infectious Diseases (NFID), who will help separate fact from fiction about avian influenza and discuss what needs to be done to prevent a future escalation.
Welcome to Managed Care Cast, where today we’re diving into a topic that’s generating national and global concern: bird flu. Despite its rarity in humans, the virus’s alarming mortality rate—nearly 50%—raises critical questions about its severity. Why is bird flu so deadly when it does infect humans, and how do factors like preexisting conditions play a role? We'll explore these questions, as well as the risks posed by current outbreaks, how avian influenza compares with other infectious diseases, and the latest on diagnostics, treatments, and vaccine development and recommendation. Joining us is Robert H. Hopkins Jr, MD, medical director at the National Foundation for Infectious Diseases (NFID) and NFID liaison to the Advisory Committee on Immunization Practices, who will help separate fact from fiction and discuss what needs to be done to prevent a future escalation.
Listen above or through one of these podcast services:
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
An Argument for Outpatient Bispecific Antibody Delivery: Dr Kirollos Hanna
January 25th 2025Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.
Read More